The Scientist

» industry

Most Recent

image: Opinion: Tales from the Nonacademic Career Path

Opinion: Tales from the Nonacademic Career Path

By | September 3, 2017

Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

image: Life Science Leaders Meet at White House

Life Science Leaders Meet at White House

By | May 8, 2017

Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.

0 Comments

image: National Academies Revise Conflict of Interest Policy

National Academies Revise Conflict of Interest Policy

By | May 3, 2017

The proposed changes follow revelations in recent years that committee members preparing reports for the Academies did not disclose industry relationships. 

2 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Addressing Biomedical Science’s PhD Problem

Addressing Biomedical Science’s PhD Problem

By | January 1, 2017

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

9 Comments

image: Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

By | December 21, 2016

Two opposing papers in Annals of Internal Medicine battle over dietary guidelines on sugar.

3 Comments

image: 2016 Salary Survey: By the Numbers

2016 Salary Survey: By the Numbers

By | November 1, 2016

This year's life sciences salary survey turned up some interesting trends in the U.S. and around the world.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

Popular Now

  1. Optimism for Key Deer After Hurricane Irma
  2. Do Microbes Trigger Alzheimer’s Disease?
  3. Decoding the Tripping Brain
  4. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

AAAS